Biological factors that affect CD95 ligand-mediated inflammation

By Seino K.   Ogino T.   Ju S.-T.   Hamada H.   Yagita H.   Okumura K.   Fukao K.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 893-895

Elsevier

Access to resources Recommend Favorite

Attempts to reveal the mechanism of CD95-ligand-mediated inflammation

By Seino K.   Ogino T.   Fukunaga K.   Taniguchi H.   Takada Y.   Yuzawa K.   Otsuka M.   Yagita H.   Okumura K.   Fukao K.  

Transplantation Proceedings, Vol. 31, Iss. 5, 1999-08 ,pp. : 1942-1943

Elsevier

Access to resources Recommend Favorite

CD4 + T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis

By Wilson A.  

International Immunology, Vol. 10, Iss. 8, 1998-08 ,pp. : 1149-1157

Oxford University Press

Access to resources Recommend Favorite

Allopeptide-mediated expression of endothelial Fas-Ligand (CD95L) in long-term tolerized heterotopic rat heart grafts

By Fandrich F.   Dresske B.   Lin X.   Huang D.S.   Zavazava N.   Henne-Bruns D.  

Transplantation Proceedings, Vol. 31, Iss. 3, 1999-05 ,pp. : 1558-1559

Elsevier

Access to resources Recommend Favorite

IFN-α enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells

By Luft T.  

International Immunology, Vol. 14, Iss. 4, 2002-04 ,pp. : 367-380

Oxford University Press

Access to resources Recommend Favorite